Supportive Care in Cancer

, Volume 13, Issue 5, pp 339–342 | Cite as

Depression and the use of complementary medicine among breast cancer patients

  • Ali Montazeri
  • Akram Sajadian
  • Mandana Ebrahimi
  • Mohammad Esmail Akbari
Short Communication

Abstract

This was a cross-sectional study to examine the association between anxiety, depression and quality of life and the use of complementary and alternative medicine. Anxiety and depression was measured using the Hospital Anxiety and Depression Scale (HADS), and quality of life was measured using the global quality of life subscale selected from the European Organization for Treatment and Research of Cancer (EORTC) quality of life core questionnaire (QLQ-C30). In all, 177 breast cancer patients were studied, and 32% (n=57) reported that they used or were using complementary medicine. Users and nonusers did not differ significantly in almost all variables studied, with the exception of duration of their diagnosis. The most commonly used complementary medicine was prayer and spiritual healing (n=45, 73.8% of responses). Performing the logistic regression analysis controlling for age, marital status, educational level, knowledge of diagnosis, time since diagnosis, global quality of life, depression, and anxiety scores, the results indicated that the use of complementary medicine among breast cancer patients was associated with sever depression (odds ratio 2.49, 95% CI 1.06–5.89, P 0.04). The other variables studied did not show any significant results. The study findings confirm that the use of complementary medicine is more common among depressed breast cancer patients and might be a marker of greater psychological distress in this group of patients.

Keywords

Complementary and alternative medicine Breast cancer Depression Iran 

References

  1. 1.
    Ashikaga T, Bosompra K, O’Brien P, Nelson L (2002) Use of complimentary and alternative medicine by breast cancer patients: prevalence, patterns and communication with physicians. Support Care Cancer 10:542–548CrossRefPubMedGoogle Scholar
  2. 2.
    Burstien HJ, Gelber S, Gundagnoil E, Weeks JC (1999) Use of alternative medicine by women with early-stage breast cancer. N Engl J Med 340:1733–1739CrossRefPubMedGoogle Scholar
  3. 3.
    Cassileth BR, Schraub S, Robinson E, Vickers A (2001) Alternative medicine use worldwide. Cancer 91:1390–1393CrossRefPubMedGoogle Scholar
  4. 4.
    Correa-Velez I, Clavarino A, Barnett AG, Eastwood H (2003) Use of complementary and alternative medicine and quality of life: changes at the end of life. Palliative Med 17:695–703Google Scholar
  5. 5.
    DiGianni LM, Garber E, Winer EP (2002) Complementary and alternative medicine use among women with breast cancer. J Clin Oncol 20 [Suppl 18]: 34s-38 sGoogle Scholar
  6. 6.
    Henderson JW, Donatelle RJ (2004) Complementary and alternative medicine use by women after allopathic treatment for breast cancer. Altern Ther Health Med 10:52–57Google Scholar
  7. 7.
    Kolstad A, Risberg T, Bremnes Y, et al (2004) Use of complementary and alternative therapies: a national multicentre study of oncology health professionals in Norway. Support Care Cancer 12:312–318CrossRefPubMedGoogle Scholar
  8. 8.
    Lengacher CA, Bennett MP, Kip KE, Keller R, LaVance MS, Smith LS, Cox CE (2002) Frequency of use of complementary and alternative medicine in women with breast cancer. Oncol Nurs Forum 29:1445–1452PubMedGoogle Scholar
  9. 9.
    Montazeri A, Harirchi I, Vahdani M, Khaleghi F, Jarvandi S, Ebrahimi M, Haji-Mahmoodi M (1999) The EORTC Quality of Life Questionnaire: translation and validation study of the Iranian version. Support Care Cancer 7:400–406CrossRefPubMedGoogle Scholar
  10. 10.
    Montazeri A, Vahdaninia M, Ebrahimi M, Jarvandi S (2003) The Hospital Anxiety and Depression Scale (HADS): translation and validation study of the Iranian version. Health and Quality of Life Outcomes 1:14 [http://www.hqlo.com/content/1/1/14]Google Scholar
  11. 11.
    Risberg T, Jacobsen BK (2003) The association between mental distress and the use of alternative medicine among cancer patients in North Norway. Qual Life Res 12:539–544CrossRefPubMedGoogle Scholar
  12. 12.
    Risberg T, Kaasa S, Wist E, Melsom H (1997) Why are cancer patients using non-proven complementary therapies? Eur J Cancer 33:575–580CrossRefPubMedGoogle Scholar
  13. 13.
    Sibbritt D, Adams J, Easthope G, Young A (2003) Complementary and alternative medicine (CAM) use among elderly Australian women who have cancer. Support Care Cancer 11:548–550CrossRefPubMedGoogle Scholar
  14. 14.
    Sollner W, Maislinger S, DeVries A, Steixner E, Rumpold G, Lukas P (2000) Use of complementary and alternative medicine by cancer patients is not associated with perceived distress or poor compliance with standard treatment but with active coping behavior: a survey. Cancer 89:873–888CrossRefPubMedGoogle Scholar
  15. 15.
    Vickers A (2004) Alternative cancer cures: ‘unproven’ or ‘disproven’. CA Cancer J Clin 54:110–118PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • Ali Montazeri
    • 1
  • Akram Sajadian
    • 1
  • Mandana Ebrahimi
    • 1
  • Mohammad Esmail Akbari
    • 1
  1. 1.Iranian Centre for Breast Cancer (ICBC)TehranIran

Personalised recommendations